amobarbital has been researched along with Catatonia in 21 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of psychogenic malignant catatonia resulting in permanent cognitive impairment." | 1.33 | Catatonia causing permanent cognitive impairment: a case study. ( Baker, IW; Bass, C; Jackson, M, 2005) |
| "Catatonia is a motor syndrome with abnormalities in neuroendocrine regulation." | 1.31 | Catatonia and ECT: Meduna's biological antagonism hypothesis reconsidered. ( Fink, M, 2002) |
| "Mutism is a common manifestation of both psychiatric and neurologic illness." | 1.27 | Mutism: review, differential diagnosis, and report of 22 cases. ( Altshuler, LL; Cummings, JL; Mills, MJ, 1986) |
| "Four of the 10 catatonia-type patients had resolution of their symptoms without recurrence." | 1.26 | The emergency amobarbital interview. ( Iserson, KV, 1980) |
| "A brief differential diagnosis of catatonia is also included." | 1.26 | Catatonia and systemic lupus erythematosus. ( Kronfol, Z; Schlesser, M; Tsuang, MT, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, M | 2 |
| RASHKIS, HA | 1 |
| SMARR, ER | 1 |
| Baker, IW | 1 |
| Jackson, M | 1 |
| Bass, C | 1 |
| Taylor, MA | 1 |
| Balhara, Y | 1 |
| Kutsenok, BM | 1 |
| Linn, L | 1 |
| Pellegrini, AJ | 1 |
| Putman, P | 1 |
| Kramer, MS | 1 |
| Perry, JC | 1 |
| Jacobs, D | 1 |
| Tollefson, GD | 1 |
| Iserson, KV | 1 |
| Dysken, MW | 1 |
| Davis, JM | 1 |
| Kronfol, Z | 1 |
| Schlesser, M | 1 |
| Tsuang, MT | 1 |
| Sacks, M | 1 |
| McCall, WV | 2 |
| Shelp, FE | 1 |
| McDonald, WM | 1 |
| Sivakumar, K | 1 |
| Mills, CS | 1 |
| Gupta, K | 1 |
| Lewis, JL | 1 |
| Santos, AB | 1 |
| Knox, EP | 1 |
| Altshuler, LL | 1 |
| Cummings, JL | 1 |
| Mills, MJ | 1 |
| Raskin, DE | 1 |
| Frank, SW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456] | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for amobarbital and Catatonia
| Article | Year |
|---|---|
Controlled investigation of the amobarbital interview for catatonic mutism.
Topics: Adult; Amobarbital; Body Weight; Catatonia; Female; Follow-Up Studies; Hospitalization; Humans; Infu | 1992 |
20 other studies available for amobarbital and Catatonia
| Article | Year |
|---|---|
Catatonia and ECT: Meduna's biological antagonism hypothesis reconsidered.
Topics: Amobarbital; Brain; Catatonia; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Hypnotics | 2002 |
Drug and milieu effects with chronic schizophrenics.
Topics: Amobarbital; Catatonia; Methylphenidate; Reserpine; Schizophrenia; Trihexyphenidyl | 1957 |
Catatonia causing permanent cognitive impairment: a case study.
Topics: Amobarbital; Attention; Catatonia; Cognition Disorders; Electroencephalography; Humans; Hypnotics an | 2005 |
Catatonia: subtype or syndrome in DSM?
Topics: Amobarbital; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lorazepam; Me | 2006 |
Catatonia or no catatonia: still beyond lorazepam/amobarbital.
Topics: Amobarbital; Catatonia; Humans; Lorazepam; Treatment Outcome | 2007 |
[On the differential diagnosis of relapsing schizophrenia].
Topics: Adolescent; Adult; Amobarbital; Catatonia; Delirium; Depression; Diagnosis, Differential; Female; Ha | 1966 |
Intravenous sedatives and catatonia.
Topics: Amobarbital; Arousal; Catatonia; Humans; Hypnotics and Sedatives; Schizophrenia, Catatonic | 1984 |
The Amytal interview in the diagnosis of late onset psychosis with cultural features presenting as catatonic stupor.
Topics: Amobarbital; Black or African American; Catatonia; Diagnosis, Differential; Humans; Male; Medicine, | 1984 |
Use of the amobarbital sleep threshold in a withdrawn catatonic patient.
Topics: Adult; Amobarbital; Catatonia; Hematoma, Subdural; Humans; Male; Sleep | 1983 |
Overview: clinical applications of the Amytal interview in psychiatric emergency settings.
Topics: Adult; Aged; Amnesia; Amobarbital; Catatonia; Combat Disorders; Depressive Disorder; Diagnosis, Diff | 1982 |
The amobarbital interview in the differential diagnosis of catatonia.
Topics: Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Middle Aged; Neurocognitive Disorde | 1982 |
The emergency amobarbital interview.
Topics: Adult; Amobarbital; Catatonia; Conversion Disorder; Emergencies; Female; Humans; Interview, Psycholo | 1980 |
Naxolone in amylobarbitone-responsive catatonia.
Topics: Adult; Amobarbital; Catatonia; Humans; Injections, Intravenous; Male; Naloxone | 1978 |
Catatonia and systemic lupus erythematosus.
Topics: Adult; Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemi | 1977 |
Amobarbital interview for catatonic patients.
Topics: Amobarbital; Catatonia; Humans; Mutism; Narcotherapy; Research Design; Suggestion | 1992 |
The addition of intravenous caffeine during an amobarbital interview.
Topics: Adult; Aged; Amobarbital; Caffeine; Catatonia; Female; Hallucinations; Humans; Injections, Intraveno | 1992 |
Abreaction before ECT?
Topics: Abreaction; Amobarbital; Catatonia; Diazepam; Electroconvulsive Therapy; Humans; Interview, Psycholo | 1991 |
Inducing catatonic patients to eat with daily administration of amobarbital sodium.
Topics: Adult; Amobarbital; Bipolar Disorder; Catatonia; Eating; Female; Humans; Infusions, Intravenous; Nut | 1989 |
Mutism: review, differential diagnosis, and report of 22 cases.
Topics: Adolescent; Adult; Aged; Amobarbital; Catatonia; Diagnosis, Differential; Female; Humans; Male; Ment | 1986 |
Herpes encephalitis with catatonic stupor.
Topics: Adult; Amobarbital; Attention; Catatonia; Diagnosis, Differential; Electroencephalography; Encephali | 1974 |